Roche and SQZ Biotech Pair Up on Immuno-Oncology

December 7, 2015 | Roche will invest as much as $500 million in a partnership with SQZ, based on a technology that physically manipulates immune cells to admit new antigens, with the aim of training these cells to fight a patient's own cancer. FierceBiotech